This phase III, multicentre, international study is conducted in 60 echocardiographic centres located in nine countries (Austria, Belgium, France, Germany, Hungary, Italy, Russia, Spain, The ...
A fixed combination of perindopril (an ACE inhibitor) plus indapamide (a diuretic), available under the brand name Preterax, was evaluated in a randomized trial (Lancet. 2007;370:829-840). Patients ...
For a follow-up discussion of the ADVANCE trial, see ADVANCE reinforces message to aggressively treat blood pressure in diabetics The study, which is being presented today at the European Society of ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
The authors evaluated, in a community-based open-label trial, the effectiveness and safety of perindopril in 13,220 US hypertensive patients and studied how physicians adhere to hypertension treatment ...
The Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) trial was a double-blind, randomized, placebo-controlled trial performed at 215 centers in 20 ...
Continuing a trend in secondary prevention, the FDA has approved perindopril for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality and ...
Background: Physical function and exercise capacity decline with age and are a major source of disability in older people. Recent evidence suggests a potential role for the renin–angiotensin system in ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback